Elfitech is powered by proprietary

technology
Simple
- Non-invasive
- Miniaturized sensor package
- Integrates with any
monitoring system
Versatile
- Works on all skin pigmentation
- Adheres to any body site
- Unaffected by ambient light
Informative
- Clinically validated perfusion data
- Deeper insights through patented algorithms and AI assisted tools
- Continuous & real-time trends
PAD is a large and growing market
Peripheral artery disease (PAD) impairs limb blood flow, making objective perfusion testing pivotal for better Diagnosis, earlier interventions, and lower complication costs
Advancing care across the PAD continuum
The same validated engine powers the FDA-cleared Faro™ Research Kit and our integrated PAD product suite. Kuro™ enables fast, affordable early PAD diagnosis, while Azora™ delivers continuous peri-operative monitoring from the OR through recovery and home care. Together, these solutions cover the full PAD continuum – from cutting-edge research to early risk detection, ongoing monitoring, and informed clinical decision-making.
Faro™
Research
The Faro™ research kit accelerates vascular discovery with a plug-and-play, non-invasive mDLS sensor that attaches to any body site, unaffected by ambient light and motion noise, and streams validated perfusion waveforms, giving scientists high-quality blood-flow insights in any lab or pre-clinical model
Kuro™
Diagnosis
Kuro™ delivers rapid, point-of-care PAD screening in primary care with a single, non-invasive 5-minute test, providing reproducible results across all skin phototypes. It integrates seamlessly into routine consultations, enabling early detection, risk stratification, and timely referral for vascular evaluation.
Azora™
Monitoring
Intra-operation | Post-operation | Home care
Azora™ delivers continuous, real-time perioperative monitoring of peripheral perfusion during and after endovascular interventions, streaming validated indices to any standard monitor to enable early intervention, prevent complications, improve outcomes, and reduce costs.
Our Team

Erez Herman, MSc, MBA
Chief Executive Officer

Roy Meidan, MD, MBA
Head of Product / Chief Medical Officer

Ilya Fine, PhD
Founder & Chief Scientific Officer

Sam Hirschman, CPA
Chief Financial Officer

Sapir Fajerzstein, MSc
Senior Algorithm Engineer

Nimrod Elstein, BSc
Director of R&D

Alex Buchman, BSc
Biomedical Engineer

Lior Keller, BSc
Product Manager

Miri Genkin, MSc
Finance & Operations Manager
Advisors

Angad Beri, MBA
Growth Strategy Advisor. Former Director of Corporate Dev at Baxter Healthcare and Thermo Fisher

Professor Irwin K.M. Reiss, MD, PhD
Head of Neonatology at Erasmus MC – Sophia Children’s Hospital. Specialist in neonatal care, pulmonary development, and intensive care research
Let’s Build the Future of PAD Care & Beyond
With over a decade of deep tech development behind us, we are now bringing our core innovation to the clinic.
Join us at this pivotal moment to create validated, scalable solutions for early diagnosis, monitoring, and intervention in PAD and beyond.
Elfitech is actively seeking strategic partners to co-develop next-generation vascular solutions – starting with PAD. Our non-invasive tissue perfusion management technology is ready to be integrated into clinical tools, surgical workflows, and vascular research.
Regulatory status: The Elfor-L clinical research system (Faro) has received FDA 510(k) clearance for measuring microvascular perfusion in human skin. It is intended for clinical and pre-clinical research applications. Elfi-Tech is ISO 13485 & 9001 certified.










